DSGN
DESIGN THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
DESIGN THERAPEUTICS INC (DSGN) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$81.94M; the largest are Baker Bros. Advisors, Steven Cohen, Renaissance Technologies. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 2 added, 3 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders51 also report options
Congress trades0
Price$12.36vs quarter-end-14.58%
Sectors0
This quarter's moves
Top holderBaker Bros. AdvisorsNew0
Added2
Trimmed / sold3
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $201.1K— of portfolio13,9002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $201.1K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.